GIP and metabolic syndrome: Interestingly, glucose-dependent insulinotropic polypeptide GIP showed a delayed plasma clearance in NASH subjects in response to an OLTT as compared to control subjects (Musso et al. 2009), which was recently confirmed in subjects with MetS compared to healthy subjects (Kardinaal et al. unpublished work).